人恶性非霍奇金淋巴瘤患者的自然杀伤细胞NK-9
| 【编号】：NK-92 【产品名称】：人恶性非霍奇金淋巴瘤患者的自然杀伤细胞NK-9 【规格】：株 【用途】：仅供研究之用   人恶性非霍奇金淋巴瘤患者的自然杀伤细胞
细胞名称：NK-92人恶性非霍奇金淋巴瘤患者的自然杀伤细胞（暂不供应）
描述：NK-92是从一位患有急进性非霍奇金淋巴瘤的50岁白人男性外周血单核细胞衍生来的一株白细胞介素-2依赖型NK细胞株。 这株细胞对很多恶性细胞有细胞毒性；铬释放试验显示它能杀死K562和Daudi细胞。 NK-92细胞(经过照射以防止增殖)可以有效地用于血液中白血病的体外免疫清扫而不危及血细胞的功能。 NK-92细胞有以下特征： CD2, CD7, CD11a, CD28, CD45, CD54表面标记阳性，CD56亮；CD1, CD3, CD4, CD5, CD8, CD10, CD14, CD16, CD19, CD20, CD23, CD34和HLA-DR表面标记阴性。
动物种别：人
性别：男
组织来源：恶性非霍奇金淋巴瘤患者的自然杀伤细胞,
形态：淋巴母细胞
培养基和添加剂：MEMα-培养基(GIBCO,货号12000022，添加NaHCO3 1.5g/L,100-200单位/ml重组 IL-2)，90%；优质胎牛血清，10%。气相：空气，95%；二氧化碳，5%。温度：37摄氏度。
供应限制：A。仅供研究之用。
REFERENCE：Gong JH , et al. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8: 652-658, 1994. PubMed: 8152260 Klingemann HG , et al. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood. Biol. Blood Marrow Transplant. 2: 68-75, 1996. PubMed: 9118301 Tam YK , et al. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10: 1359-1373, 1999. PubMed: 10365666 Klingemann HG , Miyagawa B . Purging of malignant cells from blood after short ex vivo incubation with NK-92 cells. Blood 87: 4913-1914, 1996. PubMed: 8639869 Komatsu F , Kajiwara M . Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Oncol. Res. 10: 483-489, 1998. PubMed: 10338151 Yan Y , et al. Antileukemia activity of a natural killer cell line against human leukemias. Clin. Cancer Res. 4: 2859-2868, 1998. PubMed: 9829753 Maki G , et al. Induction of sensitivity to NK-mediated cytotoxicity by TNF-alpha treatment: possible role of ICAM-3 and CD44. Leukemia 12: 1565-1572, 1998. PubMed: 9766501 Nagashima S , et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood 91: 3850-3861, 1998. PubMed: 9573023 Tam YK , et al. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother. 8: 281-290, 1999.
|
| 上一篇：人恶性非霍奇金淋巴瘤患者的自然杀伤细胞NK-9 | 下一篇：大鼠肺泡巨噬细胞NR8383 |
|---|
热销产品 新品上架